NCT00181545View on ClinicalTrials.gov

Safety Study of Individualised Radiation Dose Determination for Lung Cancer Patients.

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Non-Small-Cell Lung Carcinoma
Interventions
PROCEDURE

escalation of dose (radiotherapy treatment)

Trial Locations (1)

6411 PC

Maastircht Radiation Oncology, Heerlen

All Listed Sponsors
lead

Maastricht Radiation Oncology

OTHER

NCT00181545 - Safety Study of Individualised Radiation Dose Determination for Lung Cancer Patients. | Biotech Hunter | Biotech Hunter